| 241/458 | US=89 / Biol/Mol Vicente T, Peixoto C, Carrondo MJT, Alves PM. Virus production for clinical gene therapy. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 447-70. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9. PRODUCAO DE VIRUS; TERAPIA GENETICA CLINICA; FERRAMENTAS ANALITICAS; CARACTERIZACAO; BACULOVIRUS RECOMBINANTES; PROCESSAMENTO; VETORES VIRAIS |
| 242/458 | US=89 / Biol/Mol Kim-Schulze S, Kaufman HL. Gene therapy for antitumor vaccination. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 515-27. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9. TERAPIA GENETICA; VACINACAO ANTITUMORAL; IMUNOTERAPIA; MELANOMA; ANTIGENO TUMORAL; VIRUS VACCINIA |
| 243/458 | US=89 / Biol/Mol Simpson GR, Coffin RS. Construction and characterization of an oncolytic HSV vector containing a fusogenic glycoprotein and prodrug activation for enhanced local tumor control. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 551-64. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9. TERAPIA DO CANCER; GLICOPROTEINA DE MEMBRANA FUSOGENICA (FMG); VIRUS HERPES SIMPLEX TIPO 1 (HSV-1); ONCOLITICOS; TERAPIA DE ATIVACAO PRO-DROGA |
| 244/458 | US=85 / Biol/Mol Paternoster L, Radogna F, Accorsi A, Albertini MC, Gualandi G, Chibelli L. Melatonin as a modulator of apoptosis in B-lymphoma cells. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 345-9. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5. MELATONINA; APOPTOSE; ESPECIES REATIVAS DE OXIGENIO; B-LINFOMA LINHAS CELULARES; VIRUS EPSTEIN-BARR |
| 245/458 | US=89 / Biol/Mol Schirrmacher V, Fournier P. Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 565-605. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9. VIRUS DA DOENCA DE NEWCASTLE; TERAPIA VIRAL; TERAPIA IMUNE; TERAPIA GENICA DO CANCRO; MODULACAO IMUNE; SELETIVIDADE DO TUMOR; VACINA CONTRA TUMOR |
| 246/458 | US=89 / Biol/Mol Thirukkumaran C, Morris DG. Oncolytic viral therapy using reovirus. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 607-34. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9. |
| 247/458 | US=89 / Biol/Mol Thorne SH. Design and testing of novel oncolytic vaccinia strains. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 635-47. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9. CANCER; VIRUS ONCOLITICO; REPLICACAO SELETIVA; VACCINIA; VIROTHERAPY |
| 248/458 | US=96 / Biol/Mol Sepkovic DW, Bradlow HL. Estrogen hydroxylation - The good and the bad. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 57-67. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0. DIM; I3C; CIN; DEHP; AIF; HPV; HIDROXILACAO ESTROGENIO; DIINDOLYLMETHANE; INDOL-3-CARBINOL; CITOCROMOS; POLIMORFISMOS GENETICOS; ISOFLAVONAS DA SOJA; PAPILOMATOSE LARINGEA; NEOPLASIA CERVICAL INTEREPITHELIAL; -DI (2-ETHYLHEXY1) PHTHALETE; FATOR INIBITORIO DOS ADIPOCITOS; VIRUS DO PAPILOMA HUMANO |
| 249/458 | US=12 / Patologia Brasileiro Filho G, Pereira FEL, Guimarães RC. Distúrbios do crescimento e da diferenciação celulares. In: Brasileiro Filho G. Bogliolo: patologia geral. 4ªed. Rio de Janeiro: Guanabara - Koogan, 2009. p. 226-81. ISBN 85-2771545-4. CONTROLE DO CICLO CELULAR; CRESCIMENTO CELULAR; HIPOTROFIA; HIPERTROFIA; HIPOPLASIA; HIPERPLASIA; METAPLASIA; DISPLASIA; NEOPLASIAS; NEOPLASIAS BENIGNAS; NEOPLASIAS MALIGNAS; DISSEMINACAO DAS NEOPLASIAS; CARCIGENISE VIRAL; VIRUS DE RNA; VIRUS DE DNA; CARCINOGENISE QUIMICA; CARCINOGENESE POR RADIACAO; CRESCIMENTO TUMORAL; SISTEMICOS DA NEOPLASIAS; IMUNOTERAPIA DAS NEOPLASIAS |
| 250/458 | US=23-D / Câncer Kuramitsu Y, Nakamura K,. Hepatitis C virus-related human hepatocellular carcinoma: predictive markers using proteomic analysis (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 343-50. ISBN 978-1-4020-9803-1. VIRUS DA HEPATITE C X CARCINOMA HEPATOCELULAR HUMANO; PROTEOMICA; PROTEOMICA PARA TECIDOS DE CARCINOMA HEPATOCELULAR; PROTEOMICA PARA SOROS FROW PACIENTES COM CARCINOMA HEPATOCELULAR; PROTEOMICA PARA VIRUS DA HEPATITE C TECIDOS RELACIONADOS HEPATOCELULARES |
| 251/458 | US=14 / Nutrição Cooper A, Heird WC. Suporte nutricional de neonatos e crianças com doenças especificas ou outras condições. In: Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ. Nutrição moderna: na saúde e na doença. 10ªed. São Paulo: Manole, 2009. p. 1065-78. SUPORTE NUTRICIONAL DE NEONATOS; SUPORTE NUTRICIONAL DE CRIANCAS; FIBROSE CISTICA; DOENCA CARDIACA CONGENITA; DISTURBIOS GASTRINTESTINAIS; DIARREIA AGUDA; DOENCA DE CROHN; SINDROME DO INTESTINO CURTO; INFECCAO POR VIRUS DA IMUNODEFICIENCIA; TERAPIA NUTRICIONAL; NUTRICAO PARENTERAL |
| 252/458 | US=49-G / Câncer Benhenda S, Cougot D, Buendia MA, Neuveut C. Hepatitis B virus X protein: molecular functions and its role in life cycle and pathogenesis. In: Woude GFV, Klein G. Advances in cancer research. Amsterdam: Elsevier, 2009. p. 75-109. ISBN 978-0-12-3747730. |
| 253/458 | US=19 / Cab/Pescoço Smith IM, Califano JA, Ha PK. Molecular gene alterations as early-detection markers. In: Koch WM. Head and neck cancer. Philadelphia: Saunders Elsevier, 2010. p. 1-18. (Early diagnosis and treatment of cancer series) ISBN 978-1-4160-5202-9. ALTERACOES GENETICAS MOLECULARES; MARCADORES DE DETECCAO PRECOCE; MARCADORES MOLECULARES; ANALISE DE LINFONODOS; MODELO DE PROGRESSAO DO CANCER; MECANISMOS DE DETECCAO DO CANCER; ALTERACOES CITOGENETICAS; DETECCAO DE PCR; P53; MITOCONDRIA; METILACAO; DETECCAO DE VIRUS; PAPILOMAVIRUS HUMANO; HPV; VIRUS EPSTEIN-BARR; CARCINOMA NASOFARINGEO; NIVEIS SERICOS DE MARCADORES DE PROTEINAS; CD44; RECEPTORES DOS FATORES DE CRESCIMENTO EPITELIAIS; FATOR DE CRESCIMENTO VASCULAR ENDOTELIAL (VEGF); TECNICAS PROTEOMICAS |
| 254/458 | US=106 / Câncer LaFemina RL. Hepatitis C virus genetics and the discovery of mechanism-based inhibitors of the NS3/4A protease and NS5B polymerase. In: Nicholas J, Jeang K-T, Wu T-C. Human cancer viruses: principles of transformation and pathogenesis. Basel: Karger, 2008. p. 62-93. (Translation Research in Biomedicine) ISBN 978-3-805-58576-7. VIRUS DA HEPATITE C; MECANISMO; INIBIDORES DA PROTEASE; HEPATITE REPLICACAO DO VIRUS C; TERAPIA ANTIVIRAL ATUAL; VIRUS DA HEPATITE C NS3/4A PROTEASE |
| 255/458 | US=106 / Câncer Toh ST, Lee CG. Role of the hepatitis B virus in hepatocellular carcinoma. In: Nicholas J, Jeang K-T, Wu T-C. Human cancer viruses: principles of transformation and pathogenesis. Basel: Karger, 2008. p. 94-107. (Translation Research in Biomedicine) ISBN 978-3-805-58576-7. PAPEL DO VIRUS DA HEPATITE B. CARCINOMA HEPATOCELULAR; CARCINOMA HEPATOCELULAR; HEPATITE B VIRAL; HEPATOCARCINOGENESE |
| 256/458 | US=106 / Câncer Cougot D, Buendia MA, Neuveut C. Carcinogenesis induced by hepatitis B virus. In: Nicholas J, Jeang K-T, Wu T-C. Human cancer viruses: principles of transformation and pathogenesis. Basel: Karger, 2008. p. 108-36. (Translation Research in Biomedicine) ISBN 978-3-805-58576-7. VIRUS DA HEPATITE B, ARCINOGENESE; HEPATITE B. GENOMA DO VIRUS; PROTEINAS VIRAIS. ROPRIEDADES ONCOGENICAS; CARCINOMA HEPATOCELULAR |
| 257/458 | US=106 / Câncer Ambinder RF. Disease and pathogenesis associated with Epstein-Barr virus. In: Nicholas J, Jeang K-T, Wu T-C. Human cancer viruses: principles of transformation and pathogenesis. Basel: Karger, 2008. p. 137-49. (Translation Research in Biomedicine) ISBN 978-3-805-58576-7. VIRUS EPSTEIN-BARR; EBV; TUMORES; TUMORES ESPECIFICOS; DOENCA E PATOGENESE |
| 258/458 | US=106 / Câncer Martin HJ, Hayward SD. The biology and molecular biology underlying Epstein-Barr virus oncogenesis. In: Nicholas J, Jeang K-T, Wu T-C. Human cancer viruses: principles of transformation and pathogenesis. Basel: Karger, 2008. p. 150-69. (Translation Research in Biomedicine) ISBN 978-3-805-58576-7. VIRUS EPSTEIN-BAR. ONCOGENESE; EPSTEIN-BARR. BIOLOGIA; EPSTEIN-BARR. EXPRESSAO DE GENES PROGRAMAS; VIRUS EPSTEIN-BARR PERSISTENCIA |
| 259/458 | US=108 / Câncer Relph K, Harrington KJ, Melcher A, Pandha HS. Adenoviruses. In: Harrington KJ, Vile RG, Pandha HS. Viral therapy of cancer. New Jersey: John Wiley & Sons, 2008. p. 1-17. ISBN 978-0-470-01922-1. ADENOVIRUS; ESTRUTURA VIRAL; CICLO DE VIDA DO VIRUS; VETORES ADENOVIRAIS; TERAPIA GENICA; IMUNOTERAPIA; TERAPIA ADENOVIRAL ONCOLITICA |
| 260/458 | US=108 / Câncer Grandi P, Bein K, Hadjipanayis CG, Wolfe D, Breakefield XO, Glorioso JC. Application of HSV-1 vectors to the treatment of cancer. In: Harrington KJ, Vile RG, Pandha HS. Viral therapy of cancer. New Jersey: John Wiley & Sons, 2008. p. 19-53. ISBN 978-0-470-01922-1. CANCER. TRATAMENTO; VIRUS HERPES SIMPLES (HSV); VETORES ONCOLITICOS; VETORES DE REPLICACAO DEFEITUOSO; AMPLICONS |